Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Does Cymbalta cause erectile dysfunction? Yes, Cymbalta (duloxetine), a serotonin-noradrenaline reuptake inhibitor (SNRI), can cause erectile dysfunction in some men. This side effect is classified as 'common' in the UK Summary of Product Characteristics, affecting between 1 in 10 and 1 in 100 patients. The mechanism relates to duloxetine's effect on serotonin levels, which can interfere with the neurological and vascular processes required for erections. However, depression and anxiety—conditions Cymbalta treats—can themselves cause erectile dysfunction, making it important to distinguish medication-related from disease-related effects. Open discussion with your GP can help manage this side effect whilst maintaining effective treatment.
Summary: Cymbalta (duloxetine) can cause erectile dysfunction, classified as a 'common' side effect affecting between 1 in 10 and 1 in 100 men.
Cymbalta (duloxetine) is a serotonin-noradrenaline reuptake inhibitor (SNRI) licensed in the UK for treating major depressive disorder, generalised anxiety disorder, and diabetic peripheral neuropathic pain. Like many antidepressants, Cymbalta can affect sexual function, including causing erectile dysfunction (ED) in some men.
The mechanism behind this side effect relates to duloxetine's action on neurotransmitters in the brain and peripheral nervous system. By increasing serotonin levels, the medication can interfere with the complex neurological and vascular processes required for achieving and maintaining an erection. Serotonin plays an inhibitory role in sexual function, and elevated levels may dampen sexual desire, delay ejaculation, or impair erectile response.
Sexual dysfunction is a recognised adverse effect listed in the Summary of Product Characteristics (SmPC) for Cymbalta. According to the SmPC, erectile dysfunction is classified as a 'common' side effect in men (affecting between 1 in 10 and 1 in 100 patients). It's important to note that the underlying conditions Cymbalta treats—particularly depression and anxiety—can themselves cause or worsen erectile dysfunction, making it sometimes difficult to distinguish whether ED is medication-related or disease-related.
Patients should be aware that sexual side effects, whilst distressing, are often manageable and do not affect everyone taking the medication. Open communication with healthcare professionals is essential for addressing these concerns whilst maintaining effective treatment for the primary condition.
If you experience side effects that you think may be related to duloxetine, you can report them through the MHRA Yellow Card scheme, which helps monitor medication safety.
The reported frequency of erectile dysfunction with duloxetine varies depending on the study population and assessment methods. According to the UK SmPC, sexual dysfunction in men (including erectile dysfunction and ejaculatory dysfunction) is classified as 'common', meaning it affects between 1 in 10 and 1 in 100 patients. However, real-world prevalence may be higher, as sexual side effects are often underreported due to embarrassment or patients discontinuing medication before reporting symptoms.
Several factors may influence the risk of experiencing sexual side effects with Cymbalta:
Medication factors: Some patients may experience more pronounced effects at higher doses, though sexual dysfunction can occur at any therapeutic dose
Pre-existing sexual difficulties: Men with baseline erectile problems may experience further changes when starting antidepressants
Age: Older men generally have higher rates of erectile dysfunction due to age-related vascular changes and lower testosterone levels
Concurrent medications: Other drugs affecting sexual function (such as beta-blockers, diuretics, or additional psychotropic medications) may compound the problem
Underlying health conditions: Diabetes, cardiovascular disease, and metabolic syndrome—conditions often present in patients prescribed duloxetine for neuropathic pain—independently increase ED risk
Individual variation is considerable, and not all men taking Cymbalta will experience erectile dysfunction. The interplay between the medication, underlying psychiatric or pain conditions, psychological factors, and physical health makes predicting individual risk challenging. Importantly, depression and chronic pain themselves are strongly associated with sexual dysfunction, so improvement in the primary condition may sometimes offset medication-related effects.
If you develop erectile dysfunction whilst taking Cymbalta, several management strategies may help, and it's crucial not to stop the medication abruptly without medical guidance, as this can cause discontinuation symptoms.
Initial approaches your GP may consider include:
Watchful waiting: Sexual side effects sometimes diminish after the first few weeks as your body adjusts to the medication. If symptoms are mild and tolerable, monitoring for 4–6 weeks may be appropriate
Dose adjustment: Reducing to the lowest effective dose may help manage side effects whilst maintaining therapeutic benefit for your primary condition. This must be done under medical supervision with careful tapering
Pharmacological interventions that may be considered include:
Phosphodiesterase-5 (PDE5) inhibitors: Medications such as sildenafil, tadalafil, or vardenafil are often effective for antidepressant-induced erectile dysfunction and can be prescribed alongside Cymbalta. Sildenafil is also available over-the-counter as Viagra Connect from pharmacies following an assessment. Important: PDE5 inhibitors are contraindicated if you take nitrate medications (e.g., GTN spray/tablets) or nicorandil, and caution is needed if you have cardiovascular disease, recent heart attack or stroke, or low blood pressure
Medication switching: If sexual side effects are severe and persistent, your doctor may discuss switching to an antidepressant with a potentially lower risk of sexual dysfunction, such as mirtazapine or vortioxetine, though this depends on your specific condition and treatment response
Lifestyle modifications can also support erectile function:
Regular physical exercise improves cardiovascular health and erectile function
Weight management and control of blood glucose and cholesterol levels
Reducing alcohol consumption and stopping smoking
Managing stress through psychological therapies
Psychological support, including cognitive behavioural therapy (CBT) or psychosexual counselling, may help address performance anxiety that can develop secondary to medication-related ED. NICE guidelines recognise the importance of holistic management of sexual dysfunction, addressing both physical and psychological factors.
You should contact your GP or prescribing clinician if you experience erectile dysfunction or other sexual side effects whilst taking Cymbalta. Many patients feel embarrassed discussing these issues, but sexual health is an important component of overall wellbeing and quality of life, and healthcare professionals are accustomed to these conversations.
Specific situations warranting prompt discussion include:
New or worsening erectile dysfunction after starting Cymbalta or increasing the dose
Significant distress or impact on your relationship due to sexual side effects
Consideration of stopping medication due to sexual problems—never discontinue duloxetine abruptly without medical advice, as this can cause unpleasant withdrawal symptoms including dizziness, sensory disturbances, anxiety, and mood changes
Lack of improvement in your primary condition (depression, anxiety, or pain), which may indicate the need to reassess your treatment plan anyway
Other concerning symptoms such as loss of libido, inability to achieve orgasm, or painful ejaculation
Seek urgent medical advice if you experience:
Chest pain or angina symptoms before or during sexual activity
Painful erection or penile deformity
Erection lasting more than 4 hours (priapism) if using PDE5 inhibitors
Blood in urine or unexplained neurological symptoms
Your GP can conduct a thorough assessment to determine whether erectile dysfunction is medication-related or due to other factors. This may include:
Reviewing all your medications for potential interactions or cumulative effects
Checking for underlying physical causes with tests such as blood pressure, blood glucose, lipid profile, and possibly morning testosterone levels
Assessing cardiovascular risk factors that may affect both erectile function and treatment options
Discussing the balance between treatment benefits and side effects
NICE guidance emphasises shared decision-making in managing medication side effects. Your preferences, values, and quality of life considerations should guide treatment decisions. If Cymbalta is effectively managing your primary condition, strategies to address sexual side effects whilst continuing treatment are often preferable to switching medications. However, if side effects are intolerable, alternative treatments should be explored.
Remember that sexual dysfunction is a common and recognised side effect of many antidepressants, and discussing it openly with your healthcare team is the first step towards finding an effective solution that allows you to maintain both your mental health and sexual wellbeing.
Erectile dysfunction is classified as a 'common' side effect of Cymbalta (duloxetine), affecting between 1 in 10 and 1 in 100 men according to the UK Summary of Product Characteristics. Real-world prevalence may be higher due to underreporting.
Yes, PDE5 inhibitors such as sildenafil (Viagra) can often be prescribed alongside Cymbalta to manage erectile dysfunction. However, they are contraindicated with nitrate medications and require caution in cardiovascular disease.
Sexual side effects sometimes diminish after the first few weeks as your body adjusts to duloxetine. If symptoms persist, speak with your GP about dose adjustment, PDE5 inhibitors, or alternative antidepressants with lower sexual side effect profiles.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript